Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study
E. Trovato(Azienda Ospedaliera Universitaria Senese), Antonio Costanzo(Humanitas University), Claudia Lasagni(University of Modena and Reggio Emilia), Giovanna Moretti(Azienda Ospedaliera Ospedali Riuniti Papardo Piemonte), Aldo Cuccia(Ospedale San Donato), Fabrizio Colonna(University of Turin), Alessandro Borghi(University of Ferrara), Antonio Giovanni Richetta, Rocco De Pasquale(Azienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele), Maria Rita Bongiorno(University of Palermo), Franca Taviti(Azienda Usl Toscana Centro), Francesca Satolli(University of Parma), Massimiliano Scalvenzi, Gianluca Pagnanelli, Franco Rongioletti(Vita-Salute San Raffaele University), Federico Bardazzi(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Marina Talamonti(Policlinico Tor Vergata), Marco ROMANELLI(Scuola Superiore Sant'Anna), Marco Galluzzo(Policlinico Tor Vergata), Carlo Carrera(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Emanuele Cozzani(Ospedale Policlinico San Martino), Ketty Peris(Agostino Gemelli University Polyclinic), Francesca Prignano(University of Florence), Vincenzo Panasiti(Università Campus Bio-Medico), Marina Venturini(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Claudio Bonifati(San Gallicano Hospital)
Cited by 1
Related Papers
Dermoscopic Evaluation of Amelanotic and Hypomelanotic Melanoma
|Archives of Dermatology|2008|304
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Interactive atlas of dermoscopy
|Queensland's institutional digital repository (The University of Queensland)|2000|195
Evidence for a ‘window of opportunity’ in hidradenitis suppurativa treated with adalimumab: a retrospective, real‐life multicentre cohort study*
|British Journal of Dermatology|2020|175
European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis
|Journal of the European Academy of Dermatology and Venereology|2017|115